THE systemic use of cortisol and its derivatives has proved invaluable in the management of certain ocular diseases. However, the prolonged use of steroids, so often necessary in the treatment of such conditions as chronic uveitis, frequently leads to serious complications. The incidence of side-effects and their undesirable sequelae varies from case to case, but they are mainly related to the dosage and duration of therapy.
Patients were studied with respect to their response to the anti-inflammatory effect of steroids, and the occurrence of side-effects and complications. In a few instances, when the patients were hospitalized, their adrenal functions were studied at different stages in their treatment.
Results
At the time of the submission of this report, fifteen patients with a variety of severe ocular inflammatory diseases had been on this regimen of alternate-day steroid therapy (Table) . For obvious reasons, it is not possible to run control or double-blind studies, and we cannot evaluate this entire subject statistically. We can, however, state that, in our clinical judgment of each case, with only one exception, all our patients responded as favourably to the alternate-day regimen as they might be expected to react to the conventional dosage. The one exception was that of Case 15, who experienced a recrudescence of thyrotoxic exophthalmos a few days after being switched to the alternate-day regimen. This patient had been on daily prednisone for 2 months, and had probably developed a significant degree of adrenal cortical suppression. As a result, she had little endogenous adrenal activity, and the dosage of intermittent prednisone was relatively insufficient. The only distinctly untoward complication occurred in Case 12. This man was being given alternate-day steroids for control of sympathetic uveitis. A routine chest x ray taken during the 18th month of therapy revealed a pulmonary infiltrate. Several sputa were positive for acid-fast bacilli. Prednisone was discontinued abruptly, and only topical steroids were given. The patient was treated with anti-tubercular drugs for 2 months and tubercular signs disappeared completely. After the initial 10 days of anti-tuberculous treatment, he was again given alternate-day prednisone, which he has continued up to the present time, while under coverage of Isoniazid. Evidently the increased susceptibility of steroid-treated patients to tubercular infection is not ameliorated by this programme.
On the whole we are favourably impressed by the therapeutic effectiveness of this regimen. Several patients have maintained good adrenal cortical function in the face of long-term steroid administration which would ordinarily be expected to suppress endogenous production of cortisol. This was demonstrated both by laboratory methods (the Thorn test) and by the ability of these patients to tolerate abrupt steroid withdrawal. The desirability of avoiding adrenal suppression does not require elaboration here.
Summary
A new regimen for long-term oral dosage of steroids, which had proved itself useful in other branches of medicine, was tested in relation to ocular diseases. The longest period of treatment reported here is 2 years.
Its chief advantage over conventional steroid dosage appears to be the avoidance of adrenal cortical suppression while maintaining the anti-inflammatory effect.
There was generally a very low incidence of steroid-induced side-effects (one patient out of fourteen), but the number of patients receiving treatment was too small to draw any firm conclusions.
The treatment is recommended for any patient with normal adrenal function for whom steroid therapy is indicated, since its effectiveness is as great as conventional dosage and the side effects seem to be reduced. the treatment of ocular disease.
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